Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,274.00
Bid: 1,234.00
Ask: 1,258.00
Change: 14.00 (1.11%)
Spread: 24.00 (1.945%)
Open: 1,274.00
High: 1,274.00
Low: 1,274.00
Prev. Close: 1,260.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Market Update

7 Apr 2020 07:00

RNS Number : 9729I
Victrex PLC
07 April 2020
 

 

 

 

 

 

 

 

7 April 2020

 

Victrex plc - market update

 

 'Solid H1 trading, strong financial position, proactive actions on COVID-19'

Victrex plc, an innovative world leader in high performance polymer solutions, today announces a market update covering trading, its financial position and proactive actions on COVID-19.

H1 trading

Trading for the first half year has been solid and in line with expectations:

· Solid volume growth, including a strong finish in March

· Good growth in Automotive and Medical, with a stable performance in Aerospace, Electronics and Value-Added Resellers, offset by weakness in Energy

· H1 2020 inventory c£100m, with high sales stock across US, Europe and Asia; appropriate raw material inventory in the UK and supply chain functioning well

Strong financial position

Victrex is part of multiple supply chains, many of which are supporting critical applications, for example in Medical. The Group retains a strong balance sheet to maintain customer, supplier and investor confidence and to ensure it has sufficient resources to invest and underpin future growth:

· The Group has facilities of £40m, comprising a committed and undrawn RCF of £20m and a £20m accordion, to October 2024

· Net cash position on 31 March of £42.2m, after payment of FY19 final dividend in February

Whilst Victrex benefits from a net cash position, we are acutely aware of the near-term uncertainty at a macro and end-market level, and have prudently implemented appropriate measures to reduce cost and conserve cash, whilst maintaining strong service levels for customers:

· Capital expenditure for UK debottlenecking programme now deferred to FY 2021

· Other capital programmes limited to essential only expenditure

· Operating cost items being limited to prioritise and support customer related activity

· China capacity investment continuing on plan

Other cash conservation measures will remain under review, which could include future shareholder dividends.

 

 

 

Proactive actions on COVID-19

The safety and well-being of Victrex employees continues to be our highest priority. We established a COVID-19 committee at the start of 2020, with a proactive approach and a range of contingency plans already implemented:

· People: we continue to follow governmental or state guidance wherever we operate

· Customers: we continue to serve customers from home offices, with all of our global employees' homeworking, wherever roles are not production related

· Essential industry: the UK government defines Chemicals as an essential industry with essential workers, with Victrex also having a long-standing history in supporting many critical and "life-sustaining" applications, particularly in Medical

o UK operations: reflecting government guidance and requirements in many "life-sustaining" applications, we are continuing to produce aligned to demand, supplemented by high buffer inventory if required

o US operations: we continue to operate on an ongoing modified basis, defined as being a 'life-sustaining' organisation in several states

· Ventilators: in addition to companies we already serve, we are supplying materials for Ventilators or related equipment to a number of global companies

Outlook

Although trading has remained in line with expectations year-to-date and the third quarter has shown early signs of a solid start, including some normal demand returning across parts of Asia, the macro-economic and end-market outlook over the coming months is very uncertain, particularly for Europe and the US.

It is therefore too early to provide guidance for the remainder of the current financial year. We will continue to produce for essential business, monitoring appropriate guidelines and assessing other cash conservation measures as required.

Victrex will report its interim results on 11 May 2020.

 

About Victrex:

 

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy (including manufacturing & engineering), electronics and medical. Every day, millions of people use products and applications which contain our materials - from smartphones, aeroplanes and cars to oil and gas operations and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com or follow us on LinkedIn and Twitter @victrexir

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications

+44 (0) 7809 595831

 

Jakob Sigurdsson, Chief Executive

+44 (0) 1253 897700

 

Richard Armitage, Group Finance Director

+44 (0) 1253 897700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFLDSVIRIII
Date   Source Headline
22nd Feb 20221:14 pmRNSDirector/PDMR Shareholding
17th Feb 202212:30 pmRNSDirector/PDMR Shareholding
15th Feb 202212:12 pmRNSHolding(s) in Company
11th Feb 202212:21 pmRNSResult of AGM
11th Feb 20227:00 amRNSAGM & Q1 Interim Management Statement
10th Feb 20222:06 pmRNSDirector/PDMR Shareholding
10th Feb 202210:15 amRNSHolding(s) in Company
31st Jan 202210:23 amRNSTotal Voting Rights
28th Jan 20223:23 pmRNSHolding(s) in Company
24th Jan 20223:54 pmRNSHolding(s) in Company
20th Jan 20229:21 amRNSAdditional Listing
18th Jan 20223:11 pmRNSDirector/PDMR Shareholding
6th Jan 20222:14 pmRNSAnnual Report and Accounts
6th Jan 20229:53 amRNSDirector/PDMR Shareholding
31st Dec 20219:00 amRNSTotal Voting Rights
17th Dec 20213:59 pmRNSHolding(s) in Company
17th Dec 202112:01 pmRNSDirector/PDMR Shareholding
16th Dec 20211:06 pmRNSDirector/PDMR Shareholding
13th Dec 202111:20 amRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSVictrex plc – Preliminary Results 2021
1st Dec 20213:48 pmRNSBlock listing Interim Review
30th Nov 202111:39 amRNSTotal Voting Rights
18th Nov 20212:12 pmRNSDirector Declaration
17th Nov 202112:17 pmRNSDirector/PDMR Shareholding
9th Nov 20211:51 pmRNSDirector Declaration - Replacement
9th Nov 20219:00 amRNSDirector Declaration
29th Oct 20219:25 amRNSTotal Voting Rights
21st Oct 20217:00 amRNSVictrex signs up to SBTi
19th Oct 202111:13 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSDirectorate Change
14th Oct 20217:00 amRNSTechnipFMC to acquire Victrex’s Magma equity
30th Sep 20212:22 pmRNSTotal Voting Rights
20th Sep 20217:00 amRNSChair-designate appointment
17th Sep 202110:51 amRNSDirector/PDMR Shareholding
31st Aug 202110:23 amRNSTotal Voting Rights
18th Aug 20214:11 pmRNSDirector/PDMR Shareholding
30th Jul 202112:18 pmRNSTotal Voting Rights
19th Jul 202110:21 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202110:23 amRNSTotal Voting Rights
17th Jun 202111:29 amRNSDirector/PDMR Shareholding
16th Jun 20212:13 pmRNSAdditional Listing
2nd Jun 202111:10 amRNSDirector/PDMR Shareholding
1st Jun 20219:35 amRNSBlock listing Interim Review
28th May 20211:09 pmRNSTotal Voting Rights
18th May 20214:50 pmRNSDirector Declaration
18th May 202110:32 amRNSDirector/PDMR Shareholding
17th May 202110:56 amRNSDirector/PDMR Shareholding
13th May 202110:08 amRNSAdditional Listing
10th May 20217:00 amRNSVictrex plc Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.